Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

2.

GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.

Nakayama M, Gonzalgo ML, Yegnasubramanian S, Lin X, De Marzo AM, Nelson WG.

J Cell Biochem. 2004 Feb 15;91(3):540-52. Review.

PMID:
14755684
3.

Preneoplastic prostate lesions: an opportunity for prostate cancer prevention.

Nelson WG, De Marzo AM, Deweese TL, Lin X, Brooks JD, Putzi MJ, Nelson CP, Groopman JD, Kensler TW.

Ann N Y Acad Sci. 2001 Dec;952:135-44. Review.

PMID:
11795433
4.

Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.

Lin X, Asgari K, Putzi MJ, Gage WR, Yu X, Cornblatt BS, Kumar A, Piantadosi S, DeWeese TL, De Marzo AM, Nelson WG.

Cancer Res. 2001 Dec 15;61(24):8611-6.

5.

Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

De Marzo AM, Marchi VL, Epstein JI, Nelson WG.

Am J Pathol. 1999 Dec;155(6):1985-92.

6.

GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue.

Parsons JK, Nelson CP, Gage WR, Nelson WG, Kensler TW, De Marzo AM.

Prostate. 2001 Sep 15;49(1):30-7.

PMID:
11550208
7.

Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.

Bastian PJ, Palapattu GS, Lin X, Yegnasubramanian S, Mangold LA, Trock B, Eisenberger MA, Partin AW, Nelson WG.

Clin Cancer Res. 2005 Jun 1;11(11):4037-43.

8.

GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas.

Tchou JC, Lin X, Freije D, Isaacs WB, Brooks JD, Rashid A, De Marzo AM, Kanai Y, Hirohashi S, Nelson WG.

Int J Oncol. 2000 Apr;16(4):663-76.

PMID:
10717233
9.

Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas.

Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ.

Clin Cancer Res. 2002 Apr;8(4):1087-92.

10.

GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells.

Lin X, Tascilar M, Lee WH, Vles WJ, Lee BH, Veeraswamy R, Asgari K, Freije D, van Rees B, Gage WR, Bova GS, Isaacs WB, Brooks JD, DeWeese TL, De Marzo AM, Nelson WG.

Am J Pathol. 2001 Nov;159(5):1815-26.

11.

CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia.

Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, Epstein JI, Isaacs WB, Nelson WG.

Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):531-6.

12.

Human prostate cancer precursors and pathobiology.

De Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA, Isaacs WB, Nelson WG.

Urology. 2003 Nov;62(5 Suppl 1):55-62. Review.

PMID:
14607218
13.

Hypermethylation trigger of the glutathione-S-transferase gene (GSTP1) in prostate cancer cells.

Song JZ, Stirzaker C, Harrison J, Melki JR, Clark SJ.

Oncogene. 2002 Feb 7;21(7):1048-61.

14.

I105V polymorphism and promoter methylation of the GSTP1 gene in prostate adenocarcinoma.

Jerónimo C, Varzim G, Henrique R, Oliveira J, Bento MJ, Silva C, Lopes C, Sidransky D.

Cancer Epidemiol Biomarkers Prev. 2002 May;11(5):445-50.

15.

GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: is there a correlation with clinical stage, Gleason grade, PSA value or age?

Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A.

Eur J Med Res. 2004 Nov 29;9(11):523-7.

PMID:
15649863
16.

Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?

Bernardini S, Miano R, Iori R, Finazzi-Agrò E, Palmieri G, Ballerini S, Angeloni C, Orlandi A, Bellincampi L, Cortese C, Federici G.

Clin Chim Acta. 2004 Dec;350(1-2):181-8.

PMID:
15530476
17.

Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.

Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, von Ruecker A.

Clin Cancer Res. 2005 Jun 1;11(11):4097-106.

18.

Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer.

Millar DS, Ow KK, Paul CL, Russell PJ, Molloy PL, Clark SJ.

Oncogene. 1999 Feb 11;18(6):1313-24.

19.

Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.

Meiers I, Shanks JH, Bostwick DG.

Pathology. 2007 Jun;39(3):299-304. Review.

PMID:
17558856
20.

Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma.

Jerónimo C, Usadel H, Henrique R, Oliveira J, Lopes C, Nelson WG, Sidransky D.

J Natl Cancer Inst. 2001 Nov 21;93(22):1747-52.

PMID:
11717336

Supplemental Content

Support Center